Abstract
Purpose:To investigate the feasibility, efficiency, and delivery accuracy of volumetric modulated arc therapy with constant dose rate (VMAT‐CDR) for whole‐pelvic radiotherapy (WPRT) of endometrial cancer.Methods:The nine‐Field intensity‐modulated radiotherapy (IMRT), VMAT with variable dose‐rate (VMAT‐VDR), and VMAT‐CDR plans were created for 9 patients with endometrial cancer undergoing WPRT. The dose distribution of planning target volume (PTV), organs at risk (OARs), and normal tissue (NT) were compared. The monitor units (MUs) and treatment delivery time were also evaluated. For each VMAT‐CDR plan, a dry Run was performed to assess the dosimetric accuracy with MatriXX from IBA.Results:Compared with IMRT, the VMAT‐CDR plans delivered a slightly greater V20 of the bowel, bladder, pelvis bone, and NT, but significantly decreased the dose to the high‐dose region of the rectum and pelvis bone. The MUs Decreased from 1105 with IMRT to 628 with VMAT‐CDR. The delivery time also decreased from 9.5 to 3.2 minutes. The average gamma pass rate was 95.6% at the 3%/3 mm criteria with MatriXX pretreatment verification for 9 patients.Conclusion:VMAT‐CDR can achieve comparable plan quality with significant shorter delivery time and smaller number of MUs compared with IMRT for patients with endometrial cancer undergoing WPRT. It can be accurately delivered and be an alternative to IMRT on the linear accelerator without VDR capability.This work is supported by the grant project, National Natural; Science Foundation of China (No. 81071237).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.